X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Syntegon supplies pharma packaging lines to Pharmax in Dubai

Content Team by Content Team
24th January 2020
in Packaging & Logistic, Press Statements
Syntegon supplies pharma packaging lines to Pharmax in Dubai

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Pharmax was set up to help the UAE become more independent from imported drugs and promote the local production of generic pharmaceuticals.

With a recent requirement of mandatory health insurance for all residents, the pharmaceutical and healthcare market in the UAE is growing at a rapid pace.

The UAE Government is now strongly supporting local manufacturers to produce locally and provide the growing market with affordable equivalent medications.

The custom-built factory is equipped with the latest technology, meeting European, UAE and GMP standards.

The facility received its GMP license in March 2018 and is now producing with an annual capacity of over 200 million tablet and capsule dosage forms.

Pharmax ordered a number of different machines required for the Oral Solid Dosage (OSD) formulation plant.

The Syntegon Technology subsidiary Huettlin supplied a granulation line consisting of a Pilotmix high-shear granulator and a Pilotlab unit for optional coating in the fluid bed with a capacity range of between 15 and 60 kilograms for water-based and solvent products.

The tablets are pressed on a TPR 200, which is designed for small to medium batches. The machine can achieve an output of more than 230,000 tablets per hour. An XL Coater Lab 02 is used for tablet coating.

Further equipment includes a capsule filling and closing machine GKF 702, featuring a capsule deduster with integrated metal detector.

The GKF 702 can process between 3,000 and 42,000 capsules per hour and is suited for research and development as well as in production scale operations. With the technologies from Syntegon Technology, Pharmax covers a large part of the OSD development and production process.

Madhukar Tanna, chief executive of Pharmax, said: “When we started planning our new production, highest quality and technical support were key for us.

“Since a number of employees, including myself already had experience with Syntegon Technology, we knew about their unrivalled quality and technical support. This made the decision very easy for us.”

Previous Post

World Courier and ICS Become First End-to-End Specialty Logistics Provider for Advanced Therapies

Next Post

Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health

Herbalife Nutrition Launches Beta Heart for Better Cardiovascular Health

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In